Media Articles Related to Hycotuss (Hydrocodone / Guaifenesin)
Unexplained chronic cough treatment subject of updated evidence-based guideline
Source: Respiratory / Asthma News From Medical News Today [2015.10.02]
Persistent, unexplained cough is a significant health issue that occurs in up to 5-10 percent of patients seeking medical assistance for chronic cough.
Health Tip: What's Behind That Cough?
Source: MedicineNet Chronic Cough Specialty [2015.09.30]
Title: Health Tip: What's Behind That Cough?
Category: Health News
Created: 9/30/2015 12:00:00 AM
Last Editorial Review: 9/30/2015 12:00:00 AM
Whooping Cough (Pertussis)
Source: MedicineNet Aches, Pain, Fever Specialty [2015.09.28]
Title: Whooping Cough (Pertussis)
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 9/28/2015 12:00:00 AM
Is Whooping Cough (Pertussis) Contagious?
Source: MedicineNet Chronic Cough Specialty [2015.09.10]
Title: Is Whooping Cough (Pertussis) Contagious?
Category: Diseases and Conditions
Created: 9/10/2015 12:00:00 AM
Last Editorial Review: 9/10/2015 12:00:00 AM
Siblings Now Main Source of Infants' Whooping Cough: CDC
Source: MedicineNet Pertussis Specialty [2015.09.08]
Title: Siblings Now Main Source of Infants' Whooping Cough: CDC
Category: Health News
Created: 9/7/2015 12:00:00 AM
Last Editorial Review: 9/8/2015 12:00:00 AM
Clinical Trials Related to Hycotuss (Hydrocodone / Guaifenesin)
Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX [Recruiting]
RATIONALE: Collecting and storing samples of tumor tissue from patients with soft tissue
sarcoma to test in the laboratory may help the study of cancer in the future.
PURPOSE: This laboratory is collecting tissue samples from patients with soft tissue sarcoma
of the arms, hands, legs, or feet treated on clinical trial CRUK-VORTEX.
Functional Evaluation of Two Types of Totally Implanted Venous Ports [Completed]
Totally implanted venous access ports allow a safe delivery of medication, mainly
chemotherapy, but are also used for blood sampling. This last procedure is not always
successful, as it appeared from a nurse's survey in different hospitals in Flanders,
including the University Hospitals in Leuven, Belgium. In 3 to 29 percent of the attempts,
blood withdrawal is impaired or not possible, as an intermittent or permanent fact. This is
in line with international literature data where difficulty in blood draw was noted in 6 to
26% of port accessions. Partial or total occlusion leads to discomfort for the patient,
delay in therapy, higher costs and extra nursing time.
A new port system with a tangential outlet (Vortex port) was designed and according to the
manufacturer, this shape will allow to cleanse the entire reservoir of the port more
efficiently and avoid the formation of precipitates of medication or blood that could lead
to an obstruction of the device. These precipitates are also regarded as a potential risk
factor for infection.
However, only one previously published small randomised study addressed the value of the
Vortex port when compared to conventional access devices: Stevens et al. were able to show a
reduction in obstruction incidence from 26% to 7% with the use of the Vortex port. The
incidence of blood withdrawal problems in our experience with conventional ports in
University hospitals Leuven was 8% thus lower than that reported by Stevens, but this
remains the most frequent problem faced by care providers and patients.
With this study, the investigators aim to compare the performance of the tangential outlet
ports and that of a "conventional" port in order to assess an eventual functional
Implication of Left veNtricle Vortex Flow Guided aNticOagulation Therapy for preVenting Apical Thrombus Formation In Patients With Acute myOcardial infarctioN: Multicenter Prospective Randomized Clinical Trial; INNOVATION Study [Recruiting]
Implication of left veNtricle vortex flow guided aNticOagulation therapy for preVenting
Apical Thrombus formation In patients with acute myOcardial infarctioN: Multicenter
Prospective Randomized Clinical Trial; INNOVATION study
Impact of Enzyme Replacement Therapy on Cardiac Function in Patients With Fabry's Cardiomyopathy (RECAFTURE Trial) [Recruiting]
The purpose of this study is to evaluate the impact of ERT on LV diastolic function and flow
in patients with Fabry's cardiomyopathy using diastolic stress echocardiography, LV vortex
flow and CMR.
Fine Particle pMDI Formoterol/Beclomethasone in Asthmatics With and Without Spacer: Comparative Efficacy Evaluation [Completed]
Adequate pharmacological treatment controls symptoms in most asthmatics. Pressurized metered
dose inhalers (pMDI)are the most used drug delivery devices. Valved holding chambers of
different types and sizes have also been developed for use in combination with pMDI. The
therapeutic efficacy of treatment depends on the amount of inhaled particles. The chambers
can optimize lung deposition as it obviates lung-hand coordination and retain larger
particles. The aim of this study is to compare the efficacy of the fine particle
combination pMDI Beclomethasone/Formoterol in asthma control,with or without the aid of a
spacer in patients without adequate asthma control on medium to high-dose inhaled steroids
associated with long acting beta adrenergic drugs. The hypothesis is that there is no
clinical efficacy difference between the two forms of drug administration.